Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-067186

Chief Financial Officer acquired 15,032 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Payne Fletcher · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2015-08-20 Other acquisition : show line 1 in the form +15,032 15,032 I

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-08-20 Other acquisition : show line 2 in the form Stock Option (Right to Buy) +7,320 $7.60 2025-01-22 7,320 7,320 D
2015-08-20 Other acquisition : show line 3 in the form Stock Option (Right to Buy) +2,440 $7.60 2025-01-22 2,440 2,440 D
2015-08-20 Other acquisition : show line 4 in the form Stock Option (Right to Buy) +14,325 $6.03 2025-05-08 14,325 14,325 D
Loading xslF345X03/doc4.xml…